CVRx, Inc. (CVRX) Tops Q2 EPS by 2c; Offers FY23 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. SPCX
10. SPY

Go back to CVRx, Inc. (CVRX) Tops Q2 EPS by 2c; Offers FY23 Revenue Guidance

CVRx Reports Second Quarter 2023 Financial and Operating Results

July 25, 2023 4:15 PM EDT

MINNEAPOLIS, July 25, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (CVRx), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the second quarter of 2023.

Recent Highlights

Total revenue for the second quarter of 2023 was $9.5 million, an increase of 89% over prior year quarterU.S. Heart Failure (HF) revenue for the second quarter of 2023 was... More